Works in Breast Cancer Research, 2019, Vol 21, Issue 1

Results: 152
    1
    2
    3

    Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer.

    Published in:
    2019
    By:
    • Nederlof, Iris;
    • De Bortoli, Davide;
    • Bareche, Yacine;
    • Nguyen, Bastien;
    • de Maaker, Michiel;
    • Hooijer, Gerrit K. J.;
    • Buisseret, Laurence;
    • Kok, Marleen;
    • Smid, Marcel;
    • Van den Eynden, Gert G. G. M.;
    • Brinkman, Arie B.;
    • Hudecek, Jan;
    • Koster, Jan;
    • Sotiriou, Christos;
    • Larsimont, Denis;
    • Martens, John W. M.;
    • van de Vijver, Marc J.;
    • Horlings, Hugo M.;
    • Salgado, Roberto;
    • Biganzoli, Elia
    Publication type:
    journal article
    4

    Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers.

    Published in:
    2019
    By:
    • Viswanadhapalli, Suryavathi;
    • Ma, Shihong;
    • Sareddy, Gangadhara Reddy;
    • Lee, Tae-Kyung;
    • Li, Mengxing;
    • Gilbreath, Collin;
    • Liu, Xihui;
    • Luo, Yiliao;
    • Pratap, Uday P.;
    • Zhou, Mei;
    • Blatt, Eliot B.;
    • Kassees, Kara;
    • Arteaga, Carlos;
    • Alluri, Prasanna;
    • Rao, Manjeet;
    • Weintraub, Susan T.;
    • Tekmal, Rajeshwar Rao;
    • Ahn, Jung-Mo;
    • Raj, Ganesh V.;
    • Vadlamudi, Ratna K.
    Publication type:
    journal article
    5
    6
    7
    8
    9
    10

    Prediction and clinical utility of a contralateral breast cancer risk model.

    Published in:
    2019
    By:
    • Giardiello, Daniele;
    • Steyerberg, Ewout W.;
    • Hauptmann, Michael;
    • Adank, Muriel A.;
    • Akdeniz, Delal;
    • Blomqvist, Carl;
    • Bojesen, Stig E.;
    • Bolla, Manjeet K.;
    • Brinkhuis, Mariël;
    • Chang-Claude, Jenny;
    • Czene, Kamila;
    • Devilee, Peter;
    • Dunning, Alison M.;
    • Easton, Douglas F.;
    • Eccles, Diana M.;
    • Fasching, Peter A.;
    • Figueroa, Jonine;
    • Flyger, Henrik;
    • García-Closas, Montserrat;
    • Haeberle, Lothar
    Publication type:
    journal article
    11
    12
    13

    Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.

    Published in:
    2019
    By:
    • Sinn, Bruno Valentin;
    • Weber, Karsten E.;
    • Schmitt, Wolfgang Daniel;
    • Fasching, Peter A.;
    • Symmans, William Fraser;
    • Blohmer, Jens-Uwe;
    • Karn, Thomas;
    • Taube, Eliane Tabea;
    • Klauschen, Frederick;
    • Marmé, Frederik;
    • Schem, Christian;
    • Stickeler, Elmar;
    • Ataseven, Beyhan;
    • Huober, Jens;
    • von Minckwitz, Gunter;
    • Seliger, Barbara;
    • Denkert, Carsten;
    • Loibl, Sibylle
    Publication type:
    journal article
    14
    15
    16
    17
    18
    19
    20
    21
    22

    NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2<sup>+</sup> breast cancer.

    Published in:
    2019
    By:
    • Jacobs, Samuel A.;
    • Robidoux, André;
    • Abraham, Jame;
    • Pérez-Garcia, José Manuel;
    • La Verde, Nicla;
    • Orcutt, James M.;
    • Cazzaniga, Marina E.;
    • Piette, Fanny;
    • Antolín, Silvia;
    • Aguirre, Elena;
    • Cortes, Javier;
    • Llombart-Cussac, Antonio;
    • Di Cosimo, Serena;
    • Kim, Rim S.;
    • Feng, Huichen;
    • Lipchik, Corey;
    • Lucas, Peter C.;
    • Srinivasan, Ashok;
    • Wang, Ying;
    • Song, Nan
    Publication type:
    journal article
    23
    24
    25
    26

    Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC).

    Published in:
    2019
    By:
    • Zeinomar, Nur;
    • Knight, Julia A.;
    • Genkinger, Jeanine M.;
    • Phillips, Kelly-Anne;
    • Daly, Mary B.;
    • Milne, Roger L.;
    • Dite, Gillian S.;
    • Kehm, Rebecca D.;
    • Liao, Yuyan;
    • Southey, Melissa C.;
    • Chung, Wendy K.;
    • Giles, Graham G.;
    • McLachlan, Sue-Anne;
    • Friedlander, Michael L.;
    • Weideman, Prue C.;
    • Glendon, Gord;
    • Nesci, Stephanie;
    • Andrulis, Irene L.;
    • Buys, Saundra S.;
    • John, Esther M.
    Publication type:
    journal article
    27
    28
    29
    30
    31
    32

    Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.

    Published in:
    2019
    By:
    • Jacot, William;
    • Cottu, Paul;
    • Berger, Frederique;
    • Dubot, Coraline;
    • Venat-Bouvet, Laurence;
    • Lortholary, Alain;
    • Bourgeois, Hugues;
    • Bollet, Marc;
    • Servent, Veronique;
    • Luporsi, Elisabeth;
    • Espié, Marc;
    • Guiu, Severine;
    • D'Hondt, Veronique;
    • Dieras, Veronique;
    • Sablin, Marie-Paule;
    • Brain, Etienne;
    • Neffati, Souhir;
    • Pierga, Jean-Yves;
    • Bidard, Francois-Clement
    Publication type:
    journal article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial.

    Published in:
    2019
    By:
    • Adamo, Barbara;
    • Bellet, Meritxell;
    • Paré, Laia;
    • Pascual, Tomás;
    • Vidal, Maria;
    • Pérez Fidalgo, José A.;
    • Blanch, Salvador;
    • Martinez, Noelia;
    • Murillo, Laura;
    • Gómez-Pardo, Patricia;
    • López-González, Ana;
    • Amillano, Kepa;
    • Canes, Jordi;
    • Galván, Patricia;
    • González-Farré, Blanca;
    • González, Xavier;
    • Villagrasa, Patricia;
    • Ciruelos, Eva;
    • Prat, Aleix
    Publication type:
    journal article
    45
    46
    47
    48
    49
    50